Skip to main content

Your search for “Cancer” returned 1438 results

Study Shows Increased Prostate Cancer Risk from Vitamin E Supplements

October 18, 2011

Study Shows Increased Prostate Cancer Risk from Vitamin E Supplements Dr. J. Kellogg Parsons Men who took 400 international units (I.U.) of vitamin E daily had more prostate cancers compared to men who took a placebo, according to an updated review of data from the Selenium and Vitamin E Cancer…

Patients with Gastrointestinal Tumors at Higher Risk of Other Cancers

May 1, 2015

…temporal relationship between gastrointestinal stromal tumors (GIST) and other cancers. The results, published by Cancer on April 30, indicate that one in 5.8 patients with GIST will develop additional malignancies before and after their diagnosis.

NIH-Funded Study Shows Increased Prostate Cancer Risk from Vitamin E Supplements

October 11, 2011

…units (I.U.) of vitamin E daily had more prostate cancers compared to men who took a placebo, according to an updated review of data from the Selenium and Vitamin E Cancer Prevention (SELECT) Trial. The results of this update will appear October 12, 2011, in the Journal of the American…

Researchers Develop New Strategy to Target KRAS Mutant Cancer

September 13, 2017

In a new study, published this month in Cancer Discovery, University of California San Diego School of Medicine researchers report that approximately half of lung and pancreatic cancers that originate with a KRAS mutation become addicted to the gene as they progress.

A Father Advocates for the HPV Vaccine After Advanced Throat Cancer

August 4, 2022

…Vaccine After Advanced Throat Cancer It was a typical morning for Mike West, one that usually started with a quick shave before getting ready for work. However, this specific morning, he felt something unusual: a small, but hard lump just under his skin on his throat. West decided to call…

Targeting Newly Discovered Pathway Sensitizes Tumors to Radiation and Chemotherapy

September 3, 2015

In some patients, aggressive cancers can become resistant to chemotherapy and radiation treatments. In a paper published in the journal Nature Communications, University of California, San Diego School of Medicine researchers identified a pathway that causes the resistance and a new therapeutic drug that targets this pathway.

MicroRNA Specifically Kills Cancer Cells with Common Mutation

October 2, 2016

…percent of all human cancers have mutations in a gene called KRAS. KRAS-mutant cancers are among the most difficult to treat, with poor survival and resistance to chemotherapy. Researchers at University of California San Diego School of Medicine and Moores Cancer Center used microRNAs to systematically inhibit thousands of other…

Pandemic Upends Breast Cancer Diagnoses

February 15, 2022

UC San Diego Health researchers surveyed and compared early- and late-stage breast and colorectal cancer diagnoses in patients in pre-pandemic 2019 and in 2020, the first full year of the COVID-19 pandemic, discovering fewer of the former and more of the latter as patients delayed care.

Immunotherapy Research for Head and Neck Cancers Gets Boost from V Foundation Grant

November 27, 2017

A team of University of California San Diego School of Medicine and Moores Cancer Center researchers studying new drugs designed to break resistance to cancer immunotherapy has been awarded a V Foundation for Cancer Research translational grant of $600,000 over three years.

Editing Genes One by One Throughout Colorectal Cancer Cell Genome Uncovers New Drug Targets

September 27, 2017

Cancers driven by mutations in the KRAS gene are among the most deadly. For decades, researchers have tried unsuccessfully to directly target mutant KRAS proteins as a means to treat tumors. Instead of targeting mutant KRAS itself, researchers at University of California San Diego School of Medicine are now looking…

Category navigation with Social links